Therefore, we evaluated whether mechanisms such as protein-protein interaction between NF-κB and PPAR contribute to the changes in the expression of genes involved in cardiac fatty acid metabolism, in addition to the reported reduction in the expression of PPARs during cardiac hypertrophy [83]. The gene discussed is NFKB1; the disease is cardiac hypertrophy.